Medicare Enrolled
Dr. Francis D'Orazi, D.O.
Internal Medicine · Port Jefferson Station, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. D'Orazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. D'Orazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. D'Orazi
Dr. Francis D'Orazi is an internal medicine specialist in Port Jefferson Station, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. D'Orazi performed 4,560 Medicare services across 3,411 unique beneficiaries.
Between the years covered by Open Payments, Dr. D'Orazi received a total of $12,424 from 40 pharmaceutical and/or device companies across 572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. D'Orazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in NY
$12,424 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,560
Medicare services
Top 7% in NY for internal medicine
3,411
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~253 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
717 | $36 | $141 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $117 | $360 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
482 | $15 | $110 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
472 | $55 | $206 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
467 | $108 | $288 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
466 | $52 | $196 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $81 | $246 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
174 | $16 | $65 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
155 | $72 | $204 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
147 | $32 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
131 | $167 | $490 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
119 | $154 | $447 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
116 | $149 | $517 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
110 | $18 | $60 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
73 | $201 | $581 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
37 | $28 | $70 |
| New patient office visit, complex (60-74 min) | 33 | $205 | $580 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
22 | $50 | $130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $102 | $300 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $248 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,424
Total received (2018-2024)
Avg $1,775/year across 7 years
Top 8% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
572
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,411 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,516
2023
$2,527
2022
$2,729
2021
$1,859
2020
$770
2019
$1,047
2018
$976
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$692
AstraZeneca Pharmaceuticals LP
$540
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
Electromed, Inc.
$170
Mylan Specialty L.P.
$167
Regeneron Healthcare Solutions, Inc.
$144
Insmed, Inc.
$138
GENZYME CORPORATION
$98
Vifor Pharma, Inc.
$67
Baxter Healthcare
$59
KVK-Tech, Inc.
$49
Grifols USA, LLC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$34
Lilly USA, LLC
$33
ANI Pharmaceuticals, Inc.
$32
Genentech USA, Inc.
$27
Tandem Diabetes Care, Inc.
$21
Merck Sharp & Dohme LLC
$16
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,198
GlaxoSmithKline, LLC.
$3,076
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,528
Electromed, Inc.
$899
Grifols USA, LLC
$600
Mylan Specialty L.P.
$503
Baxter Healthcare
$401
Insmed, Inc.
$290
GENZYME CORPORATION
$259
Regeneron Healthcare Solutions, Inc.
$254
Harmony Biosciences LLC
$137
Genentech USA, Inc.
$109
Merck Sharp & Dohme LLC
$98
Exeltis, USA Inc.
$86
Inogen, Inc.
$69
Vifor Pharma, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$65
Sunovion Pharmaceuticals Inc.
$62
Amgen Inc.
$62
Lilly USA, LLC
$60
Merck Sharp & Dohme Corporation
$53
Teva Pharmaceuticals USA, Inc.
$51
ANI Pharmaceuticals, Inc.
$50
KVK-Tech, Inc.
$49
Advanced Respiratory, Inc
$48
Philips Electronics North America Corporation
$45
ADVANCED RESPIRATORY, INC
$31
Novartis Pharmaceuticals Corporation
$24
Tandem Diabetes Care, Inc.
$21
PFIZER INC.
$20
Nabriva Therapeutics, plc
$20
HARMONY BIOSCIENCES LLC
$20
OptiNose US, Inc.
$19
Circassia Pharmaceuticals Inc
$17
Xeris Pharmaceuticals, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$14
Shire North American Group Inc
$13
Mannkind Corporation
$12
Allergan Inc.
$11
Top 3 companies account for 62.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Cryvista · DIFICID · DUPIXENT · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - MetaNeb System · Hillrom - Vest System Model 105 Home Care · Hillrom - Vest System Model 205 Acute Care · Hillrom - VisiVest Airway Clearance System · INOGEN AT HOME STATIONARY CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JARDIANCE · LONHALA MAGNAIR · NUCALA · OFEV · PANZYGA · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STEGLUJAN · STIOLTO · STIOLTO RESPIMAT · STRIVERDI RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · The VisiVest Airway Clearance System · WAKIX · Wakix · XOLAIR · XYWAV · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in NY.
Geographic Context
Internal medicine physicians within 10 mi
1,069
Per 100K population
70.1
County median income
$128,329
Nearest hospital
JOHN T MATHER MEMORIAL HOSPITAL OF PORT JEFFERSON
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. D'Orazi is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. D'Orazi experienced with airflow rate measurement test?
Based on Medicare claims data, Dr. D'Orazi performed 717 airflow rate measurement test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. D'Orazi receive payments from pharmaceutical companies?
Yes. Dr. D'Orazi received a total of $12,424 from 40 companies across 572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. D'Orazi's costs compare to other internal medicine physicians in Port Jefferson Station?
Dr. D'Orazi's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. D'Orazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Port Jefferson Station
Browse internal medicine physicians in Port Jefferson Station ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology